MGMT and malignant glioma: On the other hand, methylation of the O6-methylguanine-DNA methyltransferase (MGMT) of the MGMT promoter of malignant glioma appears to be a useful predictor of the responsiveness to alkylating agents that reverse epigenetic alterations.